Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Market watchers are predicting strong growth driven by the continued success of Lilly's blockbuster medications, particularly the diabetes franchise. However, there are also concerns about potential headwinds fro